The importance of antimicrobial peptides and their potential for therapeutic use in ophthalmology

International Journal of Antimicrobial Agents

Volumn 41, Issue 1, 2013, Pages 5-10

  Silva, Nádia C ^a   Sarmento, Bruno ^b,c,d   Pintado, Manuela ^a  

^a UNIVERSIDADE CATÓLICA PORTUGUESA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c Campus de Gualtar   (Portugal)

^d INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

Author keywords

Antimicrobial peptide; Antimicrobial protein; Ocular infection; Ophthalmology

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIMICROBIAL ANIONIC PEPTIDE; ANTIMICROBIAL AROMATIC PEPTIDE; ANTIMICROBIAL CATIONIC PEPTIDE; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; BINDING PROTEIN; CATHELICIDIN; CECROPIN; DAPTOMYCIN; DEFENSIN; LACTOFERRICIN B; LACTOFERRIN; LYSOZYME; MUCIN; POLYPEPTIDE ANTIBIOTIC AGENT; TRANSFERRIN; UNCLASSIFIED DRUG;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL KERATITIS; BACTERIAL STRAIN; BACTERIUM ISOLATION; CANDIDA ALBICANS; DRUG DETERMINATION; DRUG EFFECT; DRUG POTENCY; DRUG RESPONSE; ENDOPHTHALMITIS; EYE INFECTION; FLOW RATE; HUMAN; IN VIVO STUDY; INFECTION PREVENTION; KERATOMYCOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DYNAMICS; NONHUMAN; OPHTHALMOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PNEUMONIAE; TEAR FILM; UPREGULATION;

EID: 84871656457     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.07.020     Document Type: Short Survey

References (81)

1. S.H. Marshall, and G. Arenas Antimicrobial peptides: a natural alternative to chemical antibiotics and a potential for applied biotechnology Electron J Biotechnol 6 2003 271 284
2. R.E.W. Hancock, and M.G. Scott The role of antimicrobial peptides in animal defenses Proc Natl Acad Sci USA 97 2000 8856 8861
3. A.K. Marr, W.J. Gooderham, and R.E.W. Hancock Antibacterial peptides for therapeutic use: obstacles and realistic outlook Curr Opin Pharmacol 6 2006 468 472
4. Y. Liu, J. Luo, C. Xu, F. Ren, C. Peng, and G. Wu Purification, characterization, and molecular cloning of the gene of a seed-specific antimicrobial protein from pokeweed Plant Physiol 122 2000 1015 1024
5. S. Chernysh, S.I. Kim, G. Bekeer, V.A. Pleskach, N.A. Filatova, and V.B. Anikin Antiviral and antitumor peptides from insects Proc Natl Acad Sci USA 99 2002 12628 12632
6. J.H. Andersen, S.A. Osbakk, L.H. Vorland, T. Traavik, and T.J. Gutteberg Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts Antiviral Res 51 2001 141 149
7. K.A. Daher, M.E. Selsted, and R.I. Lehrer Direct inactivation of viruses by human granulocyte defensins J Virol 60 1986 1068 1074
8. M.J. Mannis The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis Trans Am Ophthalmol Soc 99 2001 243 271
9. L. Zhang, J. Parente, S.M. Harris, D.E. Woods, R.E.W. Hancock, and T.J. Falla Antimicrobial peptide therapeutics for cystic fibrosis Antimicrob Agents Chemother 49 2005 2921 2927
10. R.E.W. Hancock, and D.S. Chapple Peptide antibiotics Antimicrob Agents Chemother 43 1999 1317 1323
11. D. Stack, C. Neville, and S. Doyle Nonribosomal peptide synthesis in Aspergillus fumigatus and other fungi Microbiology 153 2007 1297 1306
12. D. Schwarzer, H.D. Mootz, U. Linne, and M.A. Marahiel Regeneration of misprimed nonribosomal peptide synthetases by type II thioesterases Proc Natl Acad Sci USA 99 2002 14083 14088
13. T. Stein, J. Vater, V. Kruft, A. Otto, B. Wittmann-Liebold, and P. Franke The multiple carrier model of nonribosomal peptide biosynthesis at modular multienzymatic templates J Biol Chem 271 1996 15428 15435
14. J. Wiesner, and A. Vilcinskas Antimicrobial peptides: the ancient arm of the human immune system Virulence 1 2010 440 464
15. E.W. Schmidt The hidden diversity of ribosomal peptide natural products BMC Biol 8 2010 83
16. J. Vizioli, and M. Salzet Antimicrobial peptides from animals: focus on invertebrates Trends Pharmacol Sci 23 2002 494 496
17. B. Schittek, R. Hipfel, B. Sauer, J. Bauer, H. Kalbacher, and S. Stevanovic Dermcid: a novel human antibiotic peptide secreted by sweat and glands Nat Immunol 2 2001 1133 1137
18. A.C. Fogaça, P.I. da Silva Jr., M.T.M. Miranda, A.G. Bianchi, A. Miranda, and P.E.M. Ribolla Antimicrobial activity of a bovine hemoglobin fragment in the tick Boophilus microplus J Biol Chem 274 1999 25330 25334
19. A.D. Khosravi, M. Mehdinejad, and M. Heidari Bacteriological findings in patients with ocular infection and antibiotic susceptibility patterns of isolated pathogens Singapore Med J 48 2007 741 743
20. B.L. Sherwal, and A.K. Verma Epidemiology of ocular infection due to bacteria and fungus - a prospective study JK Sci 10 2008 127 131
21. E.K. Akpek, and J.D. Gottsch Immune defense at the ocular surface Eye 17 2003 949 956
22. A. Das, A.K. Dey, P.K. Agarwal, A.K. Mazumdar, S. Mazumdar, and S.S. Chatterjee Nosocomial ocular infection - a prospective study J Indian Med Assoc 101 2003 490 492
23. P.J.M. Bispo, G.B. de Melo, P.A. d'Azevedo, A.L. Höfling-Lima, M.C.Z. Yu, and A.C.C. Pignatari Culture proven bacterial endophthalmitis: a 6-year review Arq Bras Oftalmol 71 2008 617 622 [in Portuguese]
24. M.C. Callegan, M. Engelber, D.W. Parke II, B.D. Jett, and M.S. Gilmore Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions Clin Microbiol Rev 15 2002 111 124
25. D.L. Yeh, S.S. Stinnett, and N.A. Afshari Analysis of bacterial culture in infectious keratitis, 1997 to 2004 Am J Opthalmol 142 2006 1066 1068
26. S.A. Klotz, C.C. Penn, G.J. Negvesky, and S.I. Butrus Fungal and parasitic infections of the eye Clin Microbiol Rev 13 2000 662 685
27. D.A. Steinberg, M.A. Hurst, C.A. Fujii, A.H.C. Kung, J.F. Ho, and F.-C. Cheng Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity Antimicrob Agents Chemother 41 1997 1738 1742
28. L.C. Huang, D. Jean, R.J. Proske, R.Y. Reins, and A.M. McDermott Ocular surface expression and in vitro activity of antimicrobial peptides Curr Eye Res 32 2007 595 609
29. C. Zhang, D.L. Zink, M. Ushio, B. Burgess, R. Onishi, and P. Masurekar Isolation, structure, and antibacterial activity of thiazomycin A, a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa Bioorg Med Chem 16 2008 8818 8823
30. R. Manfredi, and S. Sabbatani Novel pharmaceutical molecules against emerging resistant Gram-positive cocci Braz J Infect Dis 14 2010 96 108
31. D.A. Enoch, J.M. Bygott, M.L. Daly, and J.A. Karas Daptomycin J Infect 55 2007 205 213
32. A.P. Corfield, S.D. Carrington, S.J. Hicks, M. Berry, and R. Ellingham Ocular mucins: purification, metabolism and functions Prog Retin Eye Res 16 1997 627 656
33. M. Rolando, and M. Zierhut The ocular surface and tear film and their dysfunction in dry eye disease Surv Ophthalmol 45 2001 203 210
34. M.E. Johnson, and P.J. Murphy Changes in the tear film and ocular surface from dry eye syndrome Prog Retin Eye Res 23 2004 449 474
35. R.J. Haynes, P.J. Tighe, and H.S. Dua Antimicrobial defensin peptides of the human ocular surface Br J Ophthalmol 83 1999 737 741
36. P. Huang, W. Li, J. Xie, X. Yang, D. Jiang, and S. Jiang Characterization and expression of HLysG2, a basic goose-type lysozyme from the human eye and testis Mol Immunol 48 2011 524 531
37. N. Li, C. Zhuang, M. Wang, X. Sun, S. Nie, and W. Pan Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery Int J Pharm 379 2009 131 138
38. S.M. Fleiszig, T.S. Zaidi, R. Ramphal, and G.B. Pier Modulation of Pseudomonas aeruginosa adherence to the corneal surface by mucus Infect Immun 62 1994 1799 1804
39. S.I. Butrus, and S.A. Klotz Blocking Candida adherence to contact lenses Curr Eye Res 5 1986 745 750
40. R. Kardon, R.E. Price, J. Julian, E. Lagow, S.C. Tseng, and S.J. Gendler Bacterial conjunctivitis in Muc1 null mice Invest Ophthalmol Vis Sci 40 1999 1328 1335
41. Y. Danjo, L.D. Hazlett, and I.K. Gipson C57BL/6 mice lacking Muc1 show no ocular surface phenotype Invest Ophthalmol Vis Sci 41 2000 4080 4084
42. Y. Ohashi, M. Dogru, and K. Tsubota Laboratory findings in tear fluid analysis Clin Chim Acta 369 2006 17 28
43. R.J. Fullard, and C. Snydert Protein levels in nonstimulated and stimulated tears of normal human subjects Invest Ophthalmol Vis Sci 31 1990 1119 1126
44. U.H.N. Dürr, U.S. Sudheendra, and A. Ramamoorthy LL-37, the only human member of the cathelicidin family of antimicrobial peptides Biochim Biophys Acta 1758 2006 1408 1425
45. H. Yan, and R.E. Hancock Synergistic interactions between mammalian antimicrobial defense peptides Antimicrob Agents Chemother 45 2001 1558 1560
46. S. Lee-Huang, P.L. Huang, Y.T. Sun, P.L. Huang, H.F. Kung, and D.L. Blithe Lysozyme and RNases as anti-HIV components in β-core preparations of human chorionic gonadotropin Proc Natl Aacd Sci USA 96 1999 2678 2681
47. V. Dhople, A. Krukemeyer, and A. Ramamoorthy The human β-defensin-3, an antibacterial peptide with multiple biological functions Biochim Biophys Acta 1758 2006 1499 1512
48. P. Dayhaw-Barker Corneal wound healing: II. The process Int Contact Lens Clin 22 1995 110 116
49. L. Zhou, L.Q. Huang, R.W. Beuerman, M.E. Grigg, S.F. Li, and F.T. Chew Proteomic analysis of human tears: defensin expression after ocular surface surgery J Proteome Res 3 2004 410 416
50. R.J. Haynes, J.E. McElveen, H.S. Dua, P.J. Tighe, and J. Liversidge Expression of human β-defensins in intraocular tissues Invest Ophthalmol Vis Sci 41 2000 3026 3031
51. F. Garreis, T. Schlorf, D. Worlitzsch, P. Steven, L. Bräuer, and K. Jäger Roles of human β-defensins in innate immune defense at the ocular surface: arming and alarming corneal and conjunctival epithelial cells Histochem Cell Biol 134 2010 59 73
52. + transporter in β-defensin production on the ocular surface Ann Anat 193 2011 479 485
53. R.S. McIntosh, J.E. Cade, M. Al-Abed, V. Shanmuganathan, R. Gupta, and A. Bhan The spectrum of antimicrobial peptide expression at the ocular surface Invest Ophthalmol Vis Sci 46 2005 1379 1385
54. I. Mohammed, H. Suleman, A.M. Otri, B.B. Kulkarni, P. Chen, and A. Hopkinson Localization and gene expression of human β-defensin 9 at the human ocular surface epithelium Invest Ophthalmol Vis Sci 51 2010 4677 4682
55. A.M. Otri, I. Mohammed, M.A. Al-Aqaba, U. Fares, C. Peng, and A. Hopkinson Variable expression of human β defensins 3 and 9 at the human ocular surface in infectious keratitis Invest Ophthalmol Vis Sci 53 2012 757 761
56. K. Terai, Y. Sano, S. Kawasaki, K. Endo, W. Adachi, and T. Hiratsuka Effects of dexamethasone and cyclosporine A on human β-defensin in corneal epithelial cells Exp Eye Res 79 2004 175 180
57. R.L. Redfern, R.Y. Reins, and A.M. McDermott Toll-like receptor activation modulates antimicrobial peptide expression by ocular surface cells Exp Eye Res 92 2011 209 220
58. J. Li, H.Y. Zhu, and R.W. Beuerman Stimulation of specific cytokines in human conjunctival epithelial cells by defensins HNP1, HBD2, and HBD3 Invest Ophthalmol Vis Sci 50 2009 644 653
59. O.J. Lehmann, I.R. Hussain, and P.J. Watt Investigation of β-defensin gene expression in the ocular anterior segment by semiquantitative RT-PCR Br J Ophthalmol 84 2000 523 526
60. J.S. Cullor, M.J. Mannis, C.J. Murphy, W.L. Smith, M.E. Selsted, and T.W. Reid In vitro antimicrobial activity of defensins against ocular pathogens Arch Ophthalmol 108 1990 861 864
61. Y.J. Gordon, L.C. Huang, E.G. Romanowski, K.A. Yates, R.J. Proske, and A.M. McDermott Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity Curr Eye Res 30 2005 385 394
62. M. Stoeckelhuber, E.M. Messmer, C. Schubert, B.M. Stoeckelhuber, C. Koehler, and U. Welsch Immunolocalization of defensins and cathelicidin in human glands of Moll Ann Anat 190 2008 230 237
63. L. Gunshefski, M.J. Mannis, J.S. Cullor, I.R. Schwab, J. Jaynes, and W.L. Smith In vitro antimicrobial activity of Shiva-11 against ocular pathogens Cornea 13 1994 237 242
64. K.V.R. Reddy, R.D. Yedery, and C. Aranha Antimicrobial peptides: premises and promises Int J Antimicrob Agents 24 2004 536 547
65. L.B. de Sousa In vitro use of a synthetic peptide analogous to cecropin (D5C) as an antimicrobial agent against ocular pathogens, in contact lens disinfecting solution and corneal preservation medium 1998 Department of Ophthalmology, Federal University of São Paulo, Paulista School of Medicine São Paulo, Brazil
66. M.G. Santagati, S. La Terra Mule, C. Amico, M. Pistone, D. Rusciano, and V. Enea Lactoferrin expression by bovine ocular surface epithelia: a primary cell culture model to study lactoferrin gene promoter activity Ophthalmic Res 37 2005 270 278
67. P.S. Tsai, J.E. Evans, K.M. Green, R.M. Sullivan, D.A. Schaumberg, and S.M. Richards Proteomic analysis of human meibomian gland secretions Br J Ophthalmol 90 2006 372 377
68. A. Kijlstra, S.H. Jeurissen, and K.M. Koning Lactoferrin levels in normal human tears Br J Ophthalmol 67 1983 199 202
69. J.L. Flanagan, and M.D.P. Willcox Role of lactoferrin in the tear film Biochimie 91 2009 35 43
70. J.D. Oram, and B. Reiter Inhibition of bacteria by lactoferrin and other iron-chelating agents Biochim Biophys Acta 170 1968 351 365
71. E.C. Leitch, and M.D. Willcox Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin Curr Eye Res 19 1999 12 19
72. A.B. Schryvers Characterization of the human transferrin and lactoferrin receptors in Haemophilus influenzae Mol Microbiol 2 1988 467 472
73. P. Aisen, and A. Leibman Lactoferrin and transferrin: a comparative study Biochim Biophys Acta 257 1972 314 323
74. R.N. Stuchell, R.L. Farris, and I.D. Mandel Methods of studying proteins in the tear fluid F.J. Holly, The preocular tear film in health, disease and contact lens wear 1986 Dry Eye Institute Lubbock, TX 462 470
75. J. Sengupta, S. Saha, A. Khetan, S.K. Sarkar, and S.M. Mandal Effects of lactoferricin B against keratitis-associated fungal biofilms J Infect Chemother 2012 10.1007/s10156-012-0398-3 [Epub ahead of print]
76. J.L. Gifford, H.N. Hunter, and H.J. Vogel Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties Cell Mol Life Sci 62 2005 2588 2598
77. P.C.F. Oyston, M.A. Fox, S.J. Richards, and G.C. Clark Novel peptide therapeutics for treatment of infections J Med Microbiol 58 2009 977 987
78. S. Nos-Barbera, M. Portoles, A. Morilla, J. Ubach, D. Andreu, and C.A. Paterson Effect of hybrid peptides of cecropin A and melittin in an experimental model of bacterial keratitis Cornea 16 1997 101 106
79. H. Pinto-Alphandary, A. Andremont, and P. Couvreur Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications Int J Antimicrob Agents 13 2000 155 168
80. S.C. Yadav, A. Kumari, and R. Yadav Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation Peptides 32 2011 173 187
81. D.M. Eby, K.E. Farrington, and G.R. Johnson Synthesis of bioinorganic antimicrobial peptide nanoparticles with potential therapeutic properties Biomacromolecules 9 2008 2487 2494